Concepedia

Emil M. deGoma

EM

Statistics

Publications

25

Citations

1.4K

H-Index

19

Active since

1992

Affiliations

University of Pennsylvania(Current)

Massachusetts General Hospital

Akebia Therapeutics (United States)

Stanford University

Harvard University

Emil M. deGoma is an author at University of Pennsylvania specializing in medicine, cardiovascular disease, and pharmacology.

ORCID

Publications per year

1992–2025

25

Publications

25

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States

Emil M. deGoma, Zahid Ahmad, Emily C. O’Brien et al. · Circulation Cardiovascular Genetics · 2016 · 226 citations · Full text

, , +17

Tolerization of Anti–Galα1-3Gal Natural Antibody–forming B Cells by Induction of Mixed Chimerism

Yong‐Guang Yang, Emil M. deGoma, Hideki Ohdan et al. · The Journal of Experimental Medicine · 1998 · 193 citations · Full text

, , +14

Clinical Significance of High-Density Lipoprotein Cholesterol in Patients With Low Low-Density Lipoprotein Cholesterol

Emil M. deGoma, Nicholas J. Leeper, Paul A. Heidenreich · Journal of the American College of Cardiology · 2008 · 126 citations

, , +13

Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease

Edouard Martin, Mark T. Smith, Bradley J. Maroni et al. · American Journal of Nephrology · 2017 · 123 citations · Full text

, , +17

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

John S. Millar, Gissette Reyes‐Soffer, Patricia Jumes et al. · Journal of Clinical Investigation · 2015 · 88 citations · Full text

, , +16

1–5 of 25